Capital Investors Ii L.p. Brookside is 10% at Dicerna Pharmaceuticals Inc (DRNA). They have made 1 open-market trade across 1 company since 2014, most recently 2014-03-18.
CIK 0001461876
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DRNA | 1,815,799 | $69.4M |
Shares reported on the most recent Form 4, priced at the 2014-04-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DRNA | SELL | 2014-03-11 | 2014-04-11 | $37.11 | $29.2M | -38.1% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.